Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology
- 30 April 2008
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 390 (1-2), 12-22
- https://doi.org/10.1016/j.cca.2007.12.020
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defectActa Paediatrica, 2007
- B‐type natriuretic peptide as a marker for cardiac dysfunction in anthracycline‐treated childrenPediatric Blood & Cancer, 2006
- Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme InhibitionCirculation, 2006
- The Use of a Bedside Assay for Plasma B-type Natriuretic Peptide as a Biomarker in the Management of Patent Ductus Arteriosus in Premature NeonatesThe Journal of Pediatrics, 2005
- B-type natriuretic peptide in children after cardiac transplantationThe Journal of Heart and Lung Transplantation, 2004
- Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A ReviewClinical Chemistry, 2004
- Brain natriuretic peptide concentrations in patients with aortic stenosisAmerican Heart Journal, 1997
- Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosisAmerican Heart Journal, 1997
- Brain Natriuretic Peptide Levels in the Umbilical Venous Plasma Are Elevated in Fetal DistressNeonatology, 1993
- Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factorBiochemical and Biophysical Research Communications, 1989